223 related articles for article (PubMed ID: 7016449)
1. A double-blind comparative trial of new muscle relaxant, tizanidine (DS 103-282), and baclofen in the treatment of chronic spasticity in multiple sclerosis.
Smolenski C; Muff S; Smolenski-Kautz S
Curr Med Res Opin; 1981; 7(6):374-83. PubMed ID: 7016449
[TBL] [Abstract][Full Text] [Related]
2. Multi-centre, double-blind trial of a novel antispastic agent, tizanidine, in spasticity associated with multiple sclerosis.
Eyssette M; Rohmer F; Serratrice G; Warter JM; Boisson D
Curr Med Res Opin; 1988; 10(10):699-708. PubMed ID: 3286128
[TBL] [Abstract][Full Text] [Related]
3. [Comparative double-blind study of the effectiveness and tolerance of baclofen, tetrazepam and tizanidine in spastic movement disorders of the lower extremities].
Pellkofer M; Paulig M
Med Klin (Munich); 1989 Jan; 84(1):5-8. PubMed ID: 2645508
[TBL] [Abstract][Full Text] [Related]
4. The treatment of spasticity in multiple sclerosis: a double-blind clinical trial of a new anti-spastic drug tizanidine compared with baclofen.
Stien R; Nordal HJ; Oftedal SI; Slettebø M
Acta Neurol Scand; 1987 Mar; 75(3):190-4. PubMed ID: 3554879
[TBL] [Abstract][Full Text] [Related]
5. A double-blind, long-term study of tizanidine ('Sirdalud') in spasticity due to cerebrovascular lesions.
Medici M; Pebet M; Ciblis D
Curr Med Res Opin; 1989; 11(6):398-407. PubMed ID: 2651016
[TBL] [Abstract][Full Text] [Related]
6. Tizanidine versus baclofen in the treatment of spasticity in multiple sclerosis patients.
Hoogstraten MC; van der Ploeg RJ; vd Burg W; Vreeling A; van Marle S; Minderhoud JM
Acta Neurol Scand; 1988 Mar; 77(3):224-30. PubMed ID: 3376747
[TBL] [Abstract][Full Text] [Related]
7. Tizanidine versus baclofen in the treatment of spasticity in patients with multiple sclerosis.
Bass B; Weinshenker B; Rice GP; Noseworthy JH; Cameron MG; Hader W; Bouchard S; Ebers GC
Can J Neurol Sci; 1988 Feb; 15(1):15-9. PubMed ID: 3345456
[TBL] [Abstract][Full Text] [Related]
8. Electrophysiological analysis of the mode of action of muscle relaxants in spasticity.
Delwaide PJ
Ann Neurol; 1985 Jan; 17(1):90-5. PubMed ID: 3985591
[TBL] [Abstract][Full Text] [Related]
9. Treatment of spasticity with tizanidine in multiple sclerosis.
Lapierre Y; Bouchard S; Tansey C; Gendron D; Barkas WJ; Francis GS
Can J Neurol Sci; 1987 Aug; 14(3 Suppl):513-7. PubMed ID: 3676923
[TBL] [Abstract][Full Text] [Related]
10. A multi-centre, double-blind trial of tizanidine, a new antispastic agent, in spasticity associated with hemiplegia.
Bes A; Eyssette M; Pierrot-Deseilligny E; Rohmer F; Warter JM
Curr Med Res Opin; 1988; 10(10):709-18. PubMed ID: 3286129
[TBL] [Abstract][Full Text] [Related]
11. Baclofen versus diazepam for the treatment of spasticity and long-term follow-up of baclofen therapy.
Roussan M; Terrence C; Fromm G
Pharmatherapeutica; 1985; 4(5):278-84. PubMed ID: 3906673
[TBL] [Abstract][Full Text] [Related]
12. [Tizanidine as treatment of spasticity in patients with hemiplegia caused by a CVA or brain injury].
Weynants L; Van Laere M
Acta Belg Med Phys; 1990; 13(1):19-22. PubMed ID: 2336897
[No Abstract] [Full Text] [Related]
13. Ketazolam once daily for spasticity: double-blind cross-over study.
Basmajian JV; Shankardass K; Russell D
Arch Phys Med Rehabil; 1986 Aug; 67(8):556-7. PubMed ID: 2874780
[TBL] [Abstract][Full Text] [Related]
14. Tizanidine vs. baclofen in the treatment of spasticity in patients with multiple sclerosis.
Rice GP
Can J Neurol Sci; 1989 Nov; 16(4):451. PubMed ID: 2804809
[No Abstract] [Full Text] [Related]
15. Evaluation of treatment protocols on minimal to moderate spasticity in multiple sclerosis.
Brar SP; Smith MB; Nelson LM; Franklin GM; Cobble ND
Arch Phys Med Rehabil; 1991 Mar; 72(3):186-9. PubMed ID: 1998451
[TBL] [Abstract][Full Text] [Related]
16. Development of a simple spasticity quantification method: effects of tizanidine on spasticity in patients with sequelae of cerebrovascular disease.
Ogawa N; Asanuma M; Hirata H; Ota Z; Yamawaki Y; Yamamoto M
J Int Med Res; 1992 Feb; 20(1):78-86. PubMed ID: 1568522
[TBL] [Abstract][Full Text] [Related]
17. The use of baclofen in treatment of spasticity in multiple sclerosis.
Sawa GM; Paty DW
Can J Neurol Sci; 1979 Aug; 6(3):351-4. PubMed ID: 385132
[TBL] [Abstract][Full Text] [Related]
18. [The effect of muscle relaxants on the function of the vestibulo-ocular reflex arc].
Jerábek J; Krejcová H; Cerný R; Vyskocilová M
Cesk Neurol Neurochir; 1990 Mar; 53(2):83-8. PubMed ID: 2344648
[TBL] [Abstract][Full Text] [Related]
19. Baclofen for spasticity in multiple sclerosis. Double-blind crossover and three-year study.
Feldman RG; Kelly-Hayes M; Conomy JP; Foley JM
Neurology; 1978 Nov; 28(11):1094-8. PubMed ID: 362234
[TBL] [Abstract][Full Text] [Related]
20. Flexor reflex for assessment of common interneurone activity in spasticity.
Milanov IG
Electromyogr Clin Neurophysiol; 1992 Dec; 32(12):621-9. PubMed ID: 1493777
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
